Epilogue

IF 3.9 3区 医学 Q2 CELL BIOLOGY Pigment Cell & Melanoma Research Pub Date : 2023-10-30 DOI:10.1111/pcmr.13143
Vijayasaradhi Setaluri, Evan P. and Marion Helfaer
{"title":"Epilogue","authors":"Vijayasaradhi Setaluri,&nbsp;Evan P. and Marion Helfaer","doi":"10.1111/pcmr.13143","DOIUrl":null,"url":null,"abstract":"<p>It has been an honor and privilege to serve as Editor-in-Chief of Pigment Cell &amp; Melanoma Research. This is a unique journal in many respects. It is the official journal of two scientific societies. Established first as Pigment Cell Research under the auspices of the Federation of Pigment Cell Societies, later became Pigment Cell &amp; Melanoma Research by welcoming Society for Melanoma Research to be equal partner. With this merger, the scope of manuscripts now published span the widest range of topics that include chemistry of melanin, vertebrate pigmentation, and pigmentary diseases to melanoma biology and clinical trials. I enjoyed the front row view of this expansive landscape and made every effort to make each issue reflect the scope of the journal.</p><p>I have many individuals to thank for making it a worthwhile journey. Foremost, the Associate Editors, who often shouldered equal burden, colleagues, who stepped up every time they were asked to review manuscripts, and the journal staff at Wiley, who supported the workflow. I will miss the opportunity and the privilege of being the first to glimpse research coming out from laboratories across the world. I will miss the opportunity to read the insightful reviews from researchers I hold in high esteem.</p><p>Six years ago, when I accepted to serve as Editor-in-Chief of this journal, there was some unspoken skepticism about the viability of the journal in its current form in the fast-changing landscape of journal publishing. As an optimist, I brushed aside such skepticism. Even after 6 years in the trenches, including the difficult period of COVID-19 pandemic, I remain optimistic about the future of this unique journal. There are and will be many challenges to overcome. A journal is only as good as the quality of manuscripts it receives and the peer reviews of those manuscripts. Therefore, it is my sincere hope that the members of the pigment cell and melanoma community, bound together by our interest in this fascinating entity we call “melanocyte”, choose this journal as their first choice to submit and publish their best work and be ready and willing to serve as reviewers. More than anything else, this will be a true test of the commitment of members of this community to the success of this journal. As a member of both pigment cell and melanoma societies, I commit to continue to do my part.</p>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"36 6","pages":"454"},"PeriodicalIF":3.9000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pigment Cell & Melanoma Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/pcmr.13143","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

It has been an honor and privilege to serve as Editor-in-Chief of Pigment Cell & Melanoma Research. This is a unique journal in many respects. It is the official journal of two scientific societies. Established first as Pigment Cell Research under the auspices of the Federation of Pigment Cell Societies, later became Pigment Cell & Melanoma Research by welcoming Society for Melanoma Research to be equal partner. With this merger, the scope of manuscripts now published span the widest range of topics that include chemistry of melanin, vertebrate pigmentation, and pigmentary diseases to melanoma biology and clinical trials. I enjoyed the front row view of this expansive landscape and made every effort to make each issue reflect the scope of the journal.

I have many individuals to thank for making it a worthwhile journey. Foremost, the Associate Editors, who often shouldered equal burden, colleagues, who stepped up every time they were asked to review manuscripts, and the journal staff at Wiley, who supported the workflow. I will miss the opportunity and the privilege of being the first to glimpse research coming out from laboratories across the world. I will miss the opportunity to read the insightful reviews from researchers I hold in high esteem.

Six years ago, when I accepted to serve as Editor-in-Chief of this journal, there was some unspoken skepticism about the viability of the journal in its current form in the fast-changing landscape of journal publishing. As an optimist, I brushed aside such skepticism. Even after 6 years in the trenches, including the difficult period of COVID-19 pandemic, I remain optimistic about the future of this unique journal. There are and will be many challenges to overcome. A journal is only as good as the quality of manuscripts it receives and the peer reviews of those manuscripts. Therefore, it is my sincere hope that the members of the pigment cell and melanoma community, bound together by our interest in this fascinating entity we call “melanocyte”, choose this journal as their first choice to submit and publish their best work and be ready and willing to serve as reviewers. More than anything else, this will be a true test of the commitment of members of this community to the success of this journal. As a member of both pigment cell and melanoma societies, I commit to continue to do my part.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
后记
担任《色素细胞》杂志主编是我的荣幸。黑素瘤的研究。这是一本在很多方面都很独特的杂志。它是两个科学学会的官方期刊。在色素细胞学会联合会的支持下,最初以色素细胞研究成立,后来成为色素细胞&欢迎黑色素瘤研究协会成为平等的合作伙伴。通过这次合并,现在出版的手稿范围涵盖了最广泛的主题,包括黑色素化学、脊椎动物色素沉着、色素疾病到黑色素瘤生物学和临床试验。我喜欢坐在前排欣赏这个广阔的景观,并尽一切努力使每期都能反映杂志的范围。我要感谢很多人,是他们让我的旅程变得有价值。最重要的是经常承担同等责任的副编辑、每次被要求审稿时都挺身而出的同事,以及支持整个工作流程的Wiley的期刊工作人员。我将失去第一个看到世界各地实验室的研究成果的机会和特权。我将错过阅读我所尊敬的研究人员的深刻评论的机会。六年前,当我接受这份杂志的总编辑一职时,在期刊出版业快速变化的大环境下,人们对这份杂志目前的生存能力存在着一些不言而喻的怀疑。作为一个乐观主义者,我不理会这种怀疑。即使在6年的战壕中,包括COVID-19大流行的困难时期,我仍然对这份独特期刊的未来持乐观态度。现在和将来都有许多挑战需要克服。一本期刊的好坏取决于它收到的稿件的质量和对这些稿件的同行评议。因此,我真诚地希望色素细胞和黑色素瘤社区的成员,因为我们对这个迷人的实体的兴趣而联系在一起,我们称之为“黑素细胞”,选择这本杂志作为他们提交和发表他们最好的作品的首选,并准备好并愿意担任审稿人。最重要的是,这将是对这个社区成员对这本杂志成功的承诺的真正考验。作为色素细胞和黑色素瘤协会的成员,我承诺继续尽我的一份力量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pigment Cell & Melanoma Research
Pigment Cell & Melanoma Research 医学-皮肤病学
CiteScore
8.90
自引率
2.30%
发文量
54
审稿时长
6-12 weeks
期刊介绍: Pigment Cell & Melanoma Researchpublishes manuscripts on all aspects of pigment cells including development, cell and molecular biology, genetics, diseases of pigment cells including melanoma. Papers that provide insights into the causes and progression of melanoma including the process of metastasis and invasion, proliferation, senescence, apoptosis or gene regulation are especially welcome, as are papers that use the melanocyte system to answer questions of general biological relevance. Papers that are purely descriptive or make only minor advances to our knowledge of pigment cells or melanoma in particular are not suitable for this journal. Keywords Pigment Cell & Melanoma Research, cell biology, melatonin, biochemistry, chemistry, comparative biology, dermatology, developmental biology, genetics, hormones, intracellular signalling, melanoma, molecular biology, ocular and extracutaneous melanin, pharmacology, photobiology, physics, pigmentary disorders
期刊最新文献
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State. UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production. Issue Information Bay 11-7082, an NF-κB Inhibitor, Prevents Post-Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis. Low-Dose Baricitinib Plus Narrow-Band Ultraviolet B for the Treatment of Progressive Non-Segmental Vitiligo: A Prospective, Controlled, Open-Label Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1